OK, so it's a "baker's three" (8) today. Makes up for yesterday's zero...! Patent-holder urges FDA to NOT approve prasugrel (from Lilly/Daiichi Sankyo). Novartis getting cold feet at the Alcon …
Today’s Top Three in Pharma 032609
Psychiatrists - no more $$, thanks - Amid the flak surrounding several prominent psychiatrists (see here and here) and their ties to the drug industry, the American Psychiatric Association has decided …
Why I Hate Pharma Mega-mergers
Pfizer buying Wyeth. Merck buying Schering-Plough. It's pharma mega-merger season again. I hate it. "Market conditions" | "Complementary pipelines" | "Operational synergies" blah, blah, blah. I've …
Today’s Top Three in Pharma 030609
Sanofi's giant colon visits NY. Will refrain from any further comment... Could viruses be a cause of Type 1 diabetes?? Female sex drive patch (Intrinsa) appears to be...well, impotent. PLUS - FDA …
Today’s Top Three in Pharma 021609
Takeda gets approval for Uloric - Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced today that the United States Food and …
Today’s Top Three in Pharma 020209
The FDA gives a hint of hope for the long-delayed Eli Lilly/Daiichi Sankyo drug prasugrel. Burrow deep inside this 357-page FDA document just posted online, and you’ll find this jargony but …